PubRank

Ferdinand Ploner

Author PubWeight™ 20.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 2010 2.66
2 Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol 2008 2.28
3 A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial. J Natl Cancer Inst 2008 2.07
4 Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat 2008 1.42
5 Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int J Cancer 2006 1.06
6 Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast Cancer Res Treat 2007 0.97
7 Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendation. BMC Cancer 2006 0.94
8 Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol 2002 0.90
9 Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy. Lung Cancer 2008 0.88
10 Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod Pathol 2004 0.86
11 [Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms]. Wien Klin Wochenschr 2007 0.84
12 Familial cardiac angiosarcoma. Ann Thorac Surg 2006 0.83
13 Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria. Wien Med Wochenschr 2013 0.82
14 Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients. Lung Cancer 2010 0.81
15 The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients. J Surg Oncol 2014 0.78
16 The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer. Oncol Rep 2004 0.78
17 Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med 2015 0.78
18 [Consensus diagnosis and therapy of soft tissue sarcoma]. Wien Klin Wochenschr 2011 0.77
19 Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas. Anticancer Drugs 2014 0.77
20 [Histology-based algorithm in the molecular diagnosis of mutations of the Epidernal Growth Factor Receptor (EGFR) in non-small cell lung cancer]. Wien Klin Wochenschr 2011 0.76
21 The ethics of space, design and color in an oncology ward. Palliat Support Care 2012 0.75